logo
Paroxysmal nocturnal hemoglobinuria in the era of complement inhibition
Refining prognostication of thrombosis in ET
The transfusion tether: Bridging the gap between end-stage hematologic malignancies and optimal end-of-life care
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study
Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis
18FDG-PET/CT: 21st century approach to leukemic tumors in 124 cases
Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia
Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 Mayo clinic patients
De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort
TAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenström's macroglobulinemia
Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations
Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study
Maternal opioid dose is associated with neonatal abstinence syndrome in children born to women with sickle cell disease
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload
Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI
Myeloproliferative neoplasms: Morphology and clinical practice
Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management
The fortuitous diagnosis of Burkitt lymphoma in a patient with chronic myelomonocytic leukemia
Multi-system complications of hypereosinophilia
Amyl nitrite inhalation, a “volatile” anemia
Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years
Acute myeloid leukemia with inv(16)(p13.1q22), abnormal eosinophils, and absence of peripheral blood and bone marrow blasts
Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia
Profound lymphopenia is associated with a lower risk of hepatic cytolysis during antithymocyte globulin administration
Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes